Cardinal Health, Inc. (CAH) Expected to Announce Quarterly Sales of $34.71 Billion
Equities analysts expect that Cardinal Health, Inc. (NYSE:CAH) will post sales of $34.71 billion for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Cardinal Health’s earnings. The lowest sales estimate is $34.14 billion and the highest is $35.12 billion. Cardinal Health reported sales of $33.15 billion in the same quarter last year, which would suggest a positive year over year growth rate of 4.7%. The firm is expected to announce its next earnings results on Tuesday, February 6th.
According to Zacks, analysts expect that Cardinal Health will report full-year sales of $34.71 billion for the current year, with estimates ranging from $134.39 billion to $136.94 billion. For the next fiscal year, analysts expect that the business will report sales of $141.49 billion per share, with estimates ranging from $136.83 billion to $144.42 billion. Zacks’ sales calculations are an average based on a survey of research analysts that cover Cardinal Health.
Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Monday, November 6th. The company reported $1.09 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.00 by $0.09. The firm had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $33.48 billion. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. The business’s quarterly revenue was up 1.9% on a year-over-year basis. During the same quarter last year, the company posted $1.24 EPS.
Several analysts have recently weighed in on CAH shares. Royal Bank Of Canada started coverage on shares of Cardinal Health in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $72.00 price objective on the stock. Jefferies Group LLC restated a “hold” rating and set a $77.00 price objective on shares of Cardinal Health in a research report on Thursday, July 27th. UBS AG restated a “neutral” rating and set a $76.00 price objective (down previously from $79.00) on shares of Cardinal Health in a research report on Wednesday, August 9th. Credit Suisse Group lowered their price objective on shares of Cardinal Health from $87.00 to $81.00 and set an “outperform” rating on the stock in a research report on Thursday, August 3rd. Finally, BidaskClub cut shares of Cardinal Health from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $74.81.
Cardinal Health (NYSE:CAH) traded down $2.01 during trading on Friday, hitting $58.55. 8,061,600 shares of the stock traded hands, compared to its average volume of 3,498,619. The company has a debt-to-equity ratio of 1.35, a quick ratio of 0.80 and a current ratio of 1.06. The stock has a market cap of $18,420.06, a PE ratio of 11.11, a P/E/G ratio of 1.69 and a beta of 0.88. Cardinal Health has a 12-month low of $57.54 and a 12-month high of $84.88.
The firm also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be given a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a yield of 3.16%. The ex-dividend date of this dividend is Friday, December 29th. Cardinal Health’s payout ratio is presently 53.78%.
Several hedge funds have recently added to or reduced their stakes in CAH. Fox Run Management L.L.C. purchased a new position in shares of Cardinal Health in the second quarter valued at about $234,000. Bank of Montreal Can increased its position in shares of Cardinal Health by 14.3% in the second quarter. Bank of Montreal Can now owns 696,956 shares of the company’s stock valued at $54,305,000 after acquiring an additional 87,224 shares during the period. First Financial Bank Trust Division increased its position in shares of Cardinal Health by 3.2% in the second quarter. First Financial Bank Trust Division now owns 3,695 shares of the company’s stock valued at $288,000 after acquiring an additional 114 shares during the period. State of Alaska Department of Revenue increased its position in shares of Cardinal Health by 7.6% in the second quarter. State of Alaska Department of Revenue now owns 8,773 shares of the company’s stock valued at $682,000 after acquiring an additional 618 shares during the period. Finally, National Pension Service increased its position in shares of Cardinal Health by 8.1% in the second quarter. National Pension Service now owns 282,170 shares of the company’s stock valued at $22,080,000 after acquiring an additional 21,263 shares during the period. Hedge funds and other institutional investors own 87.26% of the company’s stock.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.